Analysis for the year 2019 (Ending December 31, 2019) (Revise Template) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on
Commission Guidelines for Application and Approval for Appointment of Person to be Director or Manager of Securities Company B.E. 2553 (2010) 01/02/2010 01/02/2010 11. Notification of the Office of the
1188 FAX : +66 (0) 2625 1103 www.jubileediamond.co.th No. CS07/2020 May 12nd, 2020 Subject: Declaration of Operating Results for the 1st quarter ended 31 March 2020 Attn: Director and Manager, The Stock
PAGE 1 OF 3 GEL.CS.001/2564 1 March 2021 Subject: Management Discussion and Financial Analysis for the operating results of the year 2020 December 31, 2020 To: Director and Manager The Stock Exchange
นาสูความเปนเลิศ ทั้งในดานพาณิชยและคุณภาพผลิตภัณฑอยางเปนมืออาชพี” May 15, 2020 Subject: Clarification on the cause of changes in operating results. To: Director and Manager The Stock Exchange of
the 3rd quarter ended 30 September 2019 Attn: Director and Manager, The Stock Exchange of Thailand With respect to the financial information for the 3rd quarter ended 30 September 2019, as submitted by
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
(Ending September 30, 2019) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial for Q3
No. ACC6311/010 12 November, 2020 Subject Clarify the Operating results for quarter 3/2020 ended 30 September, 2020 Attention Director and Manager The Stock Exchange of Thailand According to Advanced
Ref: ACC6401 / 001 March 01, 2021 Subject Clarification of Operating results for the year 2020, Ending December 31, 2020 Attention: Director and Manager The Stock Exchange of Thailand As Advanced